X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (10334) 10334
Book Review (1564) 1564
Publication (906) 906
Book / eBook (121) 121
Book Chapter (83) 83
Conference Proceeding (21) 21
Dissertation (6) 6
Reference (4) 4
Data Set (3) 3
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (9795) 9795
animals (6407) 6407
humans (6130) 6130
mice (3237) 3237
phosphorylation (2421) 2421
signal transduction (2402) 2402
biochemistry & molecular biology (2199) 2199
cell biology (1877) 1877
male (1785) 1785
female (1734) 1734
rats (1604) 1604
immunology (1572) 1572
cells, cultured (1566) 1566
expression (1550) 1550
protein-tyrosine kinases - metabolism (1455) 1455
cell line (1360) 1360
oncology (1334) 1334
activation (1309) 1309
molecular sequence data (1176) 1176
receptor protein-tyrosine kinases - biosynthesis (1119) 1119
gene expression (1114) 1114
receptor (1092) 1092
proteins (1061) 1061
abridged index medicus (1054) 1054
receptor protein-tyrosine kinases - genetics (929) 929
transfection (924) 924
research (878) 878
tumor cells, cultured (855) 855
amino acid sequence (844) 844
neurosciences (813) 813
cells (803) 803
rna, messenger - biosynthesis (799) 799
receptor protein-tyrosine kinases - metabolism (751) 751
tyrosine kinase (731) 731
base sequence (728) 728
kinases (723) 723
receptors (719) 719
physiological aspects (708) 708
signal transduction - drug effects (708) 708
apoptosis (695) 695
cancer (690) 690
tyrosine (686) 686
cell line, tumor (684) 684
signal-transduction (674) 674
immunohistochemistry (661) 661
mice, inbred c57bl (660) 660
gene-expression (649) 649
signal transduction - physiology (628) 628
enzyme inhibitors - pharmacology (623) 623
protein (603) 603
adult (593) 593
proto-oncogene proteins - biosynthesis (591) 591
analysis (583) 583
multidisciplinary sciences (576) 576
endocrinology & metabolism (566) 566
protein-tyrosine kinases - antagonists & inhibitors (565) 565
pharmacology & pharmacy (546) 546
tyrosine - metabolism (544) 544
blotting, western (543) 543
article (541) 541
kinetics (535) 535
protein-tyrosine kinase (532) 532
mutation (531) 531
middle aged (527) 527
enzyme activation (526) 526
protein-tyrosine kinases - genetics (518) 518
proto-oncogene proteins - genetics (513) 513
rna, messenger - metabolism (510) 510
gene (506) 506
gene expression regulation (502) 502
mice, knockout (502) 502
physiology (500) 500
hematology (496) 496
polymerase chain reaction (494) 494
research article (489) 489
protein-tyrosine kinases - biosynthesis (483) 483
cell division - drug effects (469) 469
genetic aspects (466) 466
tyrosine phosphorylation (464) 464
ligands (463) 463
proto-oncogene proteins - metabolism (462) 462
in-vivo (443) 443
reverse transcriptase polymerase chain reaction (443) 443
rats, sprague-dawley (441) 441
proliferation (436) 436
rna, messenger - genetics (434) 434
dna - biosynthesis (427) 427
genes (414) 414
nf-kappa-b (414) 414
identification (410) 410
in-vitro (409) 409
signal transduction - immunology (407) 407
messenger-rna (406) 406
time factors (400) 400
t-lymphocytes - immunology (397) 397
growth-factor (394) 394
aged (392) 392
cell proliferation (389) 389
genetics & heredity (386) 386
growth-factor receptor (386) 386
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (86) 86
Collection Dvlpm't (Acquisitions) - Closed Orders (8) 8
UTL at Downsview - May be requested (6) 6
UofT at Mississauga - Stacks (6) 6
Online Resources - Online (5) 5
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
UofT at Scarborough - Stacks (2) 2
Chemistry (A D Allen) - Stacks (1) 1
Dentistry (Harry R Abbott) - Stacks (1) 1
Engineering & Comp. Sci. - Stacks (1) 1
Providence Healthcare - Reference (1) 1
Providence Healthcare - Stacks (1) 1
St. Michael's Hospital - Stacks (1) 1
Toronto East General Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (10434) 10434
Chinese (33) 33
Japanese (17) 17
Spanish (10) 10
French (6) 6
German (4) 4
Russian (3) 3
Swedish (2) 2
Arabic (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature, ISSN 0028-0836, 2014, Volume 508, Issue 1, pp. 118 - 122
Treatment of BRAF(V600E) mutant melanoma by small molecule drugs that target the BRAF or MEK kinases can be effective, but resistance develops invariably(1,2).... 
GROWTH-FACTOR RECEPTOR | BRAF INHIBITOR | RAF INHIBITION | CELLS | MULTIDISCIPLINARY SCIENCES | IMPROVED SURVIVAL | DIFFERENTIATION | C-JUN | CANCER | EXPRESSION | EGFR | Receptor, Epidermal Growth Factor - genetics | Humans | Receptor Protein-Tyrosine Kinases - biosynthesis | Cellular Senescence - drug effects | Melanoma - enzymology | Antineoplastic Agents - administration & dosage | Receptor, Platelet-Derived Growth Factor beta - genetics | Indoles - administration & dosage | Mitogen-Activated Protein Kinase Kinases - metabolism | Receptor, Epidermal Growth Factor - metabolism | Flow Cytometry | Melanoma - genetics | Female | Indoles - pharmacology | Antineoplastic Agents - pharmacology | Gene Expression Regulation, Neoplastic - drug effects | SOXE Transcription Factors - deficiency | Proto-Oncogene Proteins B-raf - metabolism | Receptor, Platelet-Derived Growth Factor beta - metabolism | Receptor, Epidermal Growth Factor - biosynthesis | Gene Library | Mitogen-Activated Protein Kinase Kinases - antagonists & inhibitors | Melanoma - pathology | Receptor Protein-Tyrosine Kinases - metabolism | Sulfonamides - pharmacology | Proto-Oncogene Proteins B-raf - antagonists & inhibitors | Protein Kinase Inhibitors - administration & dosage | Transforming Growth Factor beta - pharmacology | Drug Resistance, Neoplasm - genetics | Animals | Receptor Protein-Tyrosine Kinases - genetics | Signal Transduction - drug effects | Proto-Oncogene Proteins B-raf - genetics | Melanoma - drug therapy | Cell Proliferation - drug effects | Mice | Protein Kinase Inhibitors - pharmacology | RNA, Small Interfering | Transforming Growth Factor beta - metabolism | Receptor, Platelet-Derived Growth Factor beta - biosynthesis | Sulfonamides - administration & dosage | Drug Resistance, Neoplasm - drug effects | SOXE Transcription Factors - genetics | Proteins | Biopsy | Rodents | Genes | Melanoma | Mutation | Kinases | Drug resistance | Patients | Tumors | Index Medicus
Journal Article
Blood, ISSN 0006-4971, 06/2011, Volume 117, Issue 23, pp. 6287 - 6296
B-cell receptor (BCR) signaling is aberrantly activated in chronic lymphocytic leukemia (CLL). Bruton tyrosine kinase (BTK) is essential to BCR signaling and... 
B-CELLS | CLL | FLUDARABINE PLUS CYCLOPHOSPHAMIDE | APOPTOTIC CELL-DEATH | RITUXIMAB | SURVIVAL SIGNALS | LYMPHOMA | DRUG-RESISTANCE | INHIBITOR | HEMATOLOGY | EXPRESSION | T-Lymphocytes - enzymology | Apoptosis - drug effects | Humans | Tumor Necrosis Factor-alpha - genetics | Cell Survival - genetics | Apoptosis - genetics | Male | NF-kappa B - metabolism | Neoplasm Proteins - antagonists & inhibitors | Receptors, Antigen, B-Cell - metabolism | Mitogen-Activated Protein Kinase 1 - genetics | Neoplasm Proteins - genetics | Interleukin-6 - metabolism | Cell Survival - drug effects | Drug Screening Assays, Antitumor - methods | Interleukin-6 - genetics | Mitogen-Activated Protein Kinase 3 - genetics | Gene Expression Regulation, Leukemic - drug effects | Pyrimidines - pharmacology | Leukemia, Lymphocytic, Chronic, B-Cell - enzymology | B-Cell Activating Factor - metabolism | CD40 Ligand - genetics | Mitogen-Activated Protein Kinase 3 - metabolism | Gene Expression Regulation, Enzymologic - genetics | Cell Line, Tumor | Receptors, Antigen, B-Cell - genetics | Mice | Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy | Mitogen-Activated Protein Kinase 1 - metabolism | Protein-Tyrosine Kinases - antagonists & inhibitors | Tumor Necrosis Factor-alpha - metabolism | Gene Expression Regulation, Enzymologic - drug effects | Phosphatidylinositol 3-Kinases - metabolism | Gene Expression Regulation, Leukemic - genetics | Protein-Tyrosine Kinases - genetics | CD40 Ligand - metabolism | MAP Kinase Signaling System - genetics | Female | Interleukin-4 - genetics | Protein-Tyrosine Kinases - biosynthesis | Pyrazoles - pharmacology | B-Lymphocytes - enzymology | Neoplasm Proteins - biosynthesis | Interleukin-4 - metabolism | Phosphatidylinositol 3-Kinases - genetics | Animals | MAP Kinase Signaling System - drug effects | NF-kappa B - genetics | B-Cell Activating Factor - genetics | Cell Proliferation - drug effects | Index Medicus | Abridged Index Medicus | Lymphoid Neoplasia
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 08/2016, Volume 34, Issue 24, pp. 2858 - 2865
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 08/2015, Volume 21, Issue 16, pp. 3705 - 3715
Purpose: Bruton's tyrosine kinase (BTK) is a critical enzyme in the B-cell receptor pathway and is inhibited by ibrutinib due to covalent binding to the kinase... 
B-CELL RECEPTOR | TUMOR PROLIFERATION | BRUTONS TYROSINE KINASE | CLL | ONCOLOGY | BCL-2 INHIBITOR | INITIAL THERAPY | IN-VIVO | PCI-32765 | KINASE INHIBITOR IBRUTINIB | SINGLE-ARM | Piperazines - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Apoptosis - drug effects | Humans | Neoplastic Cells, Circulating - metabolism | Male | Leukemia, Lymphocytic, Chronic, B-Cell - genetics | Purines - administration & dosage | Bendamustine Hydrochloride - administration & dosage | Protein-Tyrosine Kinases - genetics | Female | bcl-X Protein - biosynthesis | Protein-Tyrosine Kinases - biosynthesis | B-Cell Activating Factor - biosynthesis | Neoplastic Cells, Circulating - drug effects | Pyrimidines - administration & dosage | Gene Expression Regulation, Leukemic - drug effects | Nitrophenols - administration & dosage | Bridged Bicyclo Compounds, Heterocyclic - administration & dosage | Proto-Oncogene Proteins c-bcl-2 - biosynthesis | Leukemia, Lymphocytic, Chronic, B-Cell - pathology | Pyrazoles - administration & dosage | B-Cell Activating Factor - genetics | Biphenyl Compounds - administration & dosage | Proto-Oncogene Proteins c-bcl-2 - antagonists & inhibitors | Aged | Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy | Isoquinolines - administration & dosage | Proto-Oncogene Proteins c-bcl-2 - genetics | Sulfonamides - administration & dosage | Index Medicus
Journal Article
Cancer Research, ISSN 0008-5472, 09/2009, Volume 69, Issue 17, pp. 6871 - 6878
Journal Article
Nature, ISSN 0028-0836, 10/2015, Volume 526, Issue 7573, pp. 453 - 457
Activation of oncogenes by mechanisms other than genetic aberrations such as mutations, translocations, or amplifications is largely undefined. Here we report... 
GENE | CHROMATIN | MULTIDISCIPLINARY SCIENCES | FRAMEWORK | RECEPTOR | NEUROBLASTOMA | MUTATIONS | DNA-SEQUENCING DATA | IDENTIFICATION | SEQ | DISCOVERY | NIH 3T3 Cells | Cell Proliferation | Molecular Weight | Histones - chemistry | Humans | Receptor Protein-Tyrosine Kinases - biosynthesis | Molecular Sequence Data | RNA, Messenger - analysis | Isoenzymes - chemistry | RNA Polymerase II - metabolism | Neoplasms - genetics | HEK293 Cells | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Female | Lysine - metabolism | Transcription Initiation, Genetic | Gene Expression Regulation, Neoplastic - genetics | Oncogenes - genetics | Introns - genetics | Signal Transduction | Isoenzymes - genetics | RNA, Messenger - genetics | Neoplasms - enzymology | Protein Structure, Tertiary - genetics | Neoplasms - drug therapy | Animals | Receptor Protein-Tyrosine Kinases - genetics | Cell Transformation, Neoplastic | Alleles | Cell Line, Tumor | Mice | Histones - metabolism | Isoenzymes - biosynthesis | Methylation | Isoenzymes - antagonists & inhibitors | Receptor Protein-Tyrosine Kinases - chemistry | Development and progression | Genetic aspects | Genetic transcription | Health aspects | Oncogenes | Cancer | Proteins | Phosphorylation | Thyroid cancer | Genes | Melanoma | Tumorigenesis | Metastasis | Kinases | Cancer therapies | Binding sites | Tumors | Index Medicus
Journal Article
Journal Article
Cancer Research, ISSN 0008-5472, 2011, Volume 71, Issue 3, pp. 852 - 861
Journal Article
Journal Article